Zobrazeno 1 - 10
of 52
pro vyhledávání: '"Justin Raymond Hamilton"'
Autor:
Sophia Xie, Paul Lacaze, Justin Raymond Hamilton, Maria V. Selvadurai, Moeen Riaz, John J McNeil, Andrew Tonkin
Publikováno v:
Thrombosis and haemostasis. 122(7)
Background Protease-activated receptor 4 (PAR4) is a platelet thrombin receptor important for thrombosis and a target of antiplatelet drug development. A frequently occurring single-nucleotide polymorphism (rs773902) causes a PAR4 sequence variant (N
Autor:
Rithwik Ramachandran, Kathryn DeFea, Nigel W. Bunnett, JoAnn Trejo, Morley D. Hollenberg, Justin Raymond Hamilton
Publikováno v:
IUPHAR/BPS Guide to Pharmacology CITE. 2021
Proteinase-activated receptors (PARs, nomenclature as agreed by the NC-IUPHAR Subcommittee on Proteinase-activated Receptors [39]) are unique members of the GPCR superfamily activated by proteolytic cleavage of their amino terminal exodomains. Agonis
Autor:
Diego Chacon, Sung K. Chiu, David J. Curtis, Mitchell J. Moon, Stephanie L. Orive, Justin Raymond Hamilton, Cedric S. Tremblay, John E. Pimanda, Dominik Beck, Benjamin T. Kile, Sarah Ellis, Yizhou Huang, Jesslyn Saw
Publikováno v:
Blood. 134:826-835
The stem cell leukemia (Scl or Tal1) protein forms part of a multimeric transcription factor complex required for normal megakaryopoiesis. However, unlike other members of this complex such as Gata1, Fli1, and Runx1, mutations of Scl have not been ob
Autor:
Mitchell J. Moon, Arnan Mitchell, Warwick Scott Nesbitt, Rose J. Brazilek, Charitha de Silva, Ivan Marusic, Crispin Szydzik, Harshal Hanumant Nandurkar, Andrew Ooi, Farzan Akbaridoust, Justin Raymond Hamilton
Publikováno v:
Analytical Chemistry. 91:10830-10839
There is a need for scalable automated lab-on-chip systems incorporating precise hemodynamic control that can be applied to high-content screening of new more efficacious antiplatelet therapies. This paper reports on the development and characterizat
Autor:
Chris Ward, Anna Bogdanova, Maggie L. Kalev-Zylinska, James I. Hearn, Marie-Christine Morel-Kopp, Justin Raymond Hamilton
Publikováno v:
Platelets. 32(8)
Ionotropic glutamate receptors include α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptors (AMPAR), kainate receptors (KAR), and N-methyl-D-aspartate receptors (NMDAR). All function as c...
Publikováno v:
Platelets. 32(7)
The thrombin receptor, protease-activated receptor 4 (PAR4), is important for platelet activation and is the target of emerging anti-thrombotic drugs. A frequently occurring single nucleotide polymorphism (SNP; rs773902) causes a function-altering PA
Autor:
Anita Eckly, Mitchell J. Moon, Christian Gachet, Jean Yves Rinckel, Harshal Hanumant Nandurkar, Peter J. Meikle, Justin Raymond Hamilton, Maria V. Selvadurai, Rose J. Brazilek, Warwick Scott Nesbitt
Publikováno v:
FEBS Letters. 593:88-96
PI3KC2α is a phosphoinositide 3-kinase with a recently reported function in platelets; PI3KC2α-deficient mouse platelets have altered membrane structure and impaired function. Yet, how these membrane changes cause platelet dysfunction remains unkno
Autor:
Mitchell J. Moon, Rose J. Brazilek, Justin Raymond Hamilton, Charitha de Silva, Farzan Akbaridoust, Harshal Hanumant Nandurkar, Arnan Mitchell, Ivan Marusic, Warwick Scott Nesbitt, Crispin Szydzik
Publikováno v:
SPIE Micro + Nano Materials, Devices, and Applications 2019.
This work reports on development and characterization of an on-chip microfluidic handling system for application in preclinical anti-platelet drug screening. A reciprocating elastomeric micropump/mixer design is presented for use with whole human blo
Autor:
Justin Raymond Hamilton, Rithwik Ramachandran, JoAnn Trejo, Nigel W. Bunnett, Kathryn DeFea, Morley D. Hollenberg
Publikováno v:
IUPHAR/BPS Guide to Pharmacology CITE. 2019
Proteinase-activated receptors (PARs, nomenclature as agreed by the NC-IUPHAR Subcommittee on Proteinase-activated Receptors [35]) are unique members of the GPCR superfamily activated by proteolytic cleavage of their amino terminal exodomains. Agonis
Autor:
Maria V. Selvadurai, Aleksandra Adamska, Krithika Sundaram, Justin Raymond Hamilton, Philip E. Thompson, Marco Falasca
Publikováno v:
Journal of Medicinal Chemistry. 60:47-65
The phosphoinositide 3-kinases (PI3Ks) are a family of lipid kinases central to regulating a wide range of important intracellular processes. Despite the vast knowledge around class I PI3Ks, the class II PI3Ks have been neglected, seemingly only due